Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute (Cellular) Renal Allograft Rejection”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)Study completedNCT00866879
What this trial is testing

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

Who this might be right for
Renal Transplant Rejection
Northwestern University 275
Post-approval studies (Phase 4)UnknownNCT02102854
What this trial is testing

Single Dose rATG for Renal Allograft Rejection

Who this might be right for
Acute (Cellular) Renal Allograft Rejection
The Methodist Hospital Research Institute 30
Not applicableStudy completedNCT06476717
What this trial is testing

Donor-derived Cell-free DNA in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAcute Rejection of Renal Transplant
Institute for Clinical and Experimental Medicine 143
Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Testing effectiveness (Phase 2)Study completedNCT00805909
What this trial is testing

NI-0401 in Patients With Acute Renal Allograft Rejection

Who this might be right for
Acute Renal Transplant Rejection
Light Chain Bioscience - Novimmune SA 12
Not applicableWithdrawnNCT05423496
What this trial is testing

KidneyCare Immuno-optimization in Renal Allografts (KIRA)

Who this might be right for
Kidney TransplantImmunosuppressionAllograft
CareDx
Testing effectiveness (Phase 2)Study completedNCT00235300
What this trial is testing

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Who this might be right for
Cadaveric Donor Renal TransplantationAcute Renal Allograft RejectionInduction Therapy
Genzyme, a Sanofi Company 240
Testing effectiveness (Phase 2)Study completedNCT00771875
What this trial is testing

Randomized Trial for Mixed Acute Rejection

Who this might be right for
Graft Rejection
University of Cincinnati 30
Not applicableActive Not RecruitingNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Not applicableStudy completedNCT00695097
What this trial is testing

The Effect of Rituximab on the Development of Anti-Donor Antibodies

Who this might be right for
Renal Transplant Rejection
University of California, San Francisco 18
Not applicableActive Not RecruitingNCT05477082
What this trial is testing

Blood Biomarkers in Pediatric Kidney Transplant Recipients

Who this might be right for
Rejection of Kidney Allograft
University of Minnesota 27
Testing effectiveness (Phase 2)Study completedNCT00089947
What this trial is testing

Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Who this might be right for
Renal TransplantationGraft Rejection
Genzyme, a Sanofi Company 150